Articles

The EMA’s CHMP has adopted a positive opinion recommending marketing authorization for Moderna’s COVID-19 vaccine (Spikevax) to include adolescents 12 years of age and older.

EMA’s CHMP Adopts Positive Opinion for Moderna COVID-19 Vaccine Use in Adolescents 

Kadmon Pharmaceuticals selects Onco360 to be a specialty pharmacy partner for Rezurock (belumosudil).

Kadmon Pharmaceuticals Partners with Oncology Pharmacy for New Chronic Graft-Versus-Host Disease Therapy

The companies collaborate to develop and commercialize ARV-471, an investigational oral PROTAC (proteolysis targeting chimeras) estrogen receptor protein degrader.

Pfizer and Arvinas to Develop and Commercialize Estrogen Receptor Targeting Breast Cancer 

J&J to contribute up to $5 billion to the settlement agreement to resolve opioid-related claims and litigation in the United States. 

Johnson & Johnson Finalizes National Opioid Settlement Agreement 

Aenova has announced plans to open a new new can and bottle filling production line in Cornu, Romania. 

Aenova Announces Plans for New Production Line

Summa Equity has acquired a majority stake in G-CON Manufacturing, a prefabricated cleanroom provider. 

Summa Equity Acquires Cleanroom Provider G-CON Manufacturing

Pfizer Inc. and BioNTech SE announced the signing of a letter of intent with The Biovac Institute Ltd to manufacture the Pfizer-BioNTech COVID-19 vaccine for distribution within the African Union.

Pfizer and BioNTech Announce Collaboration with Biovac to Manufacture and Distribute COVID-19 Vaccine Doses Within Africa

Catalent Biologics has launched its new cell line expression technology, GPEx Lightning, which aims to shorten drug substance development timelines by up to three months.

Catalent Biologics Launches New Cell Line Expression Technology

Sinovac Biotech’s Eupolio vaccine, a Sabin inactivated poliovirus vaccine (sIPV), has gained marketing authorization in China.

Sinovac’s Eupolio Vaccine Gains Market Authorization in China

Exscientia and GT Apeiron Therapeutics have entered into a strategic R&D oncology collaboration agreement.

News